NFKB1 and polycystic ovary syndrome: Given the prominence of the AGEs-RAGE/NOX4/NF-κB pathway in driving PCOS pathogenesis, as outlined above, we hypothesized that BSTJF might ameliorate PCOS by modulating this oxidative-inflammatory pathway.